| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/27/2023 | 11.52% | Stephens & Co. | $112 → $100 | Maintains | Equal-Weight |
| 09/27/2023 | 8.17% | Truist Securities | $113 → $97 | Maintains | Hold |
| 09/27/2023 | 21.56% | Morgan Stanley | $116 → $109 | Maintains | Equal-Weight |
| 08/25/2023 | 11.52% | UBS | $97 → $100 | Upgrades | Sell → Neutral |
| 07/31/2023 | 40.52% | DA Davidson | $134 → $126 | Maintains | Buy |
| 07/28/2023 | 24.9% | Wedbush | $120 → $112 | Maintains | Neutral |
| 07/28/2023 | 36.05% | RBC Capital | $127 → $122 | Maintains | Sector Perform |
| 07/28/2023 | 30.48% | Stephens & Co. | $121 → $117 | Maintains | Equal-Weight |
| 07/07/2023 | 29.36% | Morgan Stanley | $121 → $116 | Maintains | Equal-Weight |
| 06/29/2023 | 50.55% | JP Morgan | $130 → $135 | Maintains | Overweight |
| 06/29/2023 | 26.02% | Truist Securities | $114 → $113 | Maintains | Hold |
| 05/16/2023 | 34.94% | Morgan Stanley | $127 → $121 | Downgrades | Overweight → Equal-Weight |
| 04/28/2023 | 33.82% | Wedbush | $110 → $120 | Maintains | Neutral |
| 04/28/2023 | 42.75% | Keefe, Bruyette & Woods | $132 → $128 | Maintains | Market Perform |
| 04/05/2023 | 41.63% | Morgan Stanley | $168 → $127 | Maintains | Overweight |
| 03/23/2023 | 27.13% | Truist Securities | $136 → $114 | Maintains | Hold |
| 02/21/2023 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 02/01/2023 | 51.67% | Truist Securities | $148 → $136 | Maintains | Hold |
| 01/27/2023 | 56.13% | Stephens & Co. | $154 → $140 | Maintains | Equal-Weight |
| 01/27/2023 | 56.13% | Wedbush | $150 → $140 | Maintains | Neutral |
| 01/27/2023 | 67.28% | Raymond James | $165 → $150 | Maintains | Outperform |
| 01/05/2023 | 72.86% | B of A Securities | → $155 | Upgrades | Neutral → Buy |
| 12/21/2022 | 63.93% | DA Davidson | → $147 | Initiates Coverage On | → Buy |
| 12/13/2022 | 72.86% | JP Morgan | $175 → $155 | Maintains | Overweight |
| 12/05/2022 | 98.51% | Morgan Stanley | → $178 | Initiates Coverage On | → Overweight |
| 11/03/2022 | — | Wolfe Research | Downgrades | Outperform → Peer Perform | |
| 10/31/2022 | 78.43% | Evercore ISI Group | $140 → $160 | Upgrades | Underperform → In-Line |
| 10/28/2022 | 81.78% | Stephens & Co. | $149 → $163 | Maintains | Equal-Weight |
| 10/28/2022 | 78.43% | RBC Capital | $148 → $160 | Maintains | Sector Perform |
| 10/28/2022 | 84.01% | Raymond James | $150 → $165 | Maintains | Outperform |
| 09/28/2022 | 56.13% | Wedbush | → $140 | Assumes | → Neutral |
| 09/14/2022 | 67.28% | Truist Securities | $140 → $150 | Maintains | Hold |
| 08/15/2022 | 69.51% | Compass Point | → $152 | Upgrades | Neutral → Buy |
| 08/02/2022 | 61.7% | Stephens & Co. | $133 → $145 | Maintains | Equal-Weight |
| 08/01/2022 | 57.24% | Wedbush | → $141 | Upgrades | Underperform → Neutral |
| 07/29/2022 | 67.28% | Raymond James | $145 → $150 | Maintains | Outperform |
| 07/13/2022 | 42.75% | Compass Point | → $128 | Upgrades | Sell → Neutral |
| 07/07/2022 | 61.7% | Raymond James | $160 → $145 | Maintains | Outperform |
| 06/15/2022 | 72.86% | JP Morgan | $143 → $155 | Upgrades | Underweight → Overweight |
| 06/13/2022 | 49.44% | Truist Securities | $149 → $134 | Maintains | Hold |
| 05/26/2022 | 47.21% | Wolfe Research | $161 → $132 | Maintains | Outperform |
| 04/07/2022 | 90.7% | Wolfe Research | $157 → $171 | Upgrades | Underperform → Outperform |
| 04/06/2022 | 78.43% | Raymond James | → $160 | Upgrades | Market Perform → Outperform |
| 01/28/2022 | — | Raymond James | Upgrades | Underperform → Market Perform | |
| 12/06/2021 | 20.44% | Morgan Stanley | $100 → $108 | Maintains | Underweight |
| 11/01/2021 | 11.52% | Morgan Stanley | $96 → $100 | Maintains | Underweight |
| 10/29/2021 | 50.55% | RBC Capital | $126 → $135 | Maintains | Sector Perform |
| 10/29/2021 | 49.44% | Stephens & Co. | $120 → $134 | Maintains | Equal-Weight |
| 10/01/2021 | 44.98% | Truist Securities | $117 → $130 | Maintains | Hold |
| 05/04/2021 | 7.06% | Morgan Stanley | $90 → $96 | Maintains | Underweight |
| 05/03/2021 | 49.44% | Truist Securities | $111 → $134 | Maintains | Hold |
| 03/18/2021 | 0.37% | Morgan Stanley | $85 → $90 | Maintains | Underweight |
| 03/08/2021 | 23.79% | Truist Securities | $96 → $111 | Maintains | Hold |
| 02/24/2021 | -5.21% | Morgan Stanley | $81 → $85 | Maintains | Underweight |
| 01/07/2021 | -9.67% | Morgan Stanley | $75 → $81 | Maintains | Underweight |
| 12/07/2020 | -16.36% | Morgan Stanley | $64 → $75 | Maintains | Underweight |
| 11/12/2020 | -10.78% | Keefe, Bruyette & Woods | → $80 | Downgrades | Outperform → Market Perform |
| 11/11/2020 | -20.82% | Compass Point | $69 → $71 | Downgrades | Neutral → Sell |
| 11/03/2020 | -28.63% | Morgan Stanley | $65 → $64 | Maintains | Underweight |
| 06/08/2020 | -27.51% | Morgan Stanley | $63 → $65 | Maintains | Underweight |
| 05/18/2020 | -33.09% | CFRA | $91 → $60 | Maintains | Sell |
| 05/01/2020 | -13.01% | SunTrust Robinson Humphrey | $64 → $78 | Maintains | Hold |
| 05/01/2020 | -33.09% | B of A Securities | $53 → $60 | Reiterates | → Underperform |
| 04/07/2020 | -29.74% | Morgan Stanley | $72 → $63 | Maintains | Underweight |
| 03/17/2020 | -19.71% | Morgan Stanley | $78 → $72 | Maintains | Underweight |
| 03/09/2020 | -13.01% | Morgan Stanley | $82 → $78 | Maintains | Underweight |
| 03/06/2020 | -10.78% | SunTrust Robinson Humphrey | $104 → $80 | Downgrades | Buy → Hold |
| 03/05/2020 | -8.55% | Morgan Stanley | $89 → $82 | Maintains | Underweight |
| 02/13/2020 | 8.17% | Stephens & Co. | $104 → $97 | Maintains | Equal-Weight |
| 01/31/2020 | — | Evercore ISI Group | Downgrades | In-Line → Underperform | |
| 11/04/2019 | -0.75% | Morgan Stanley | $92 → $89 | Maintains | Underweight |
| 11/01/2019 | — | Wedbush | Downgrades | Neutral → Underperform | |
| 10/03/2019 | 2.6% | Morgan Stanley | $94 → $92 | Maintains | Underweight |
| 09/16/2019 | 17.1% | SunTrust Robinson Humphrey | $108 → $105 | Maintains | Buy |
| 07/11/2019 | — | B of A Securities | Downgrades | Neutral → Underperform | |
| 04/26/2019 | 5.94% | Wedbush | $94 → $95 | Maintains | Neutral |
| 01/10/2019 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 12/11/2018 | 10.4% | Morgan Stanley | $103 → $99 | Maintains | Underweight |
| 11/12/2018 | 14.87% | Morgan Stanley | $105 → $103 | Downgrades | Equal-Weight → Underweight |
| 10/29/2018 | 17.1% | SunTrust Robinson Humphrey | $124 → $105 | Maintains | Buy |
What is the target price for Cullen/Frost Bankers (CFR)?
The latest price target for Cullen/Frost Bankers (NYSE: CFR) was reported by Stephens & Co. on October 27, 2023. The analyst firm set a price target for $100.00 expecting CFR to rise to within 12 months (a possible 11.52% upside). 30 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cullen/Frost Bankers (CFR)?
The latest analyst rating for Cullen/Frost Bankers (NYSE: CFR) was provided by Stephens & Co., and Cullen/Frost Bankers maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Cullen/Frost Bankers (CFR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cullen/Frost Bankers, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cullen/Frost Bankers was filed on October 27, 2023 so you should expect the next rating to be made available sometime around October 27, 2024.
Is the Analyst Rating Cullen/Frost Bankers (CFR) correct?
While ratings are subjective and will change, the latest Cullen/Frost Bankers (CFR) rating was a maintained with a price target of $112.00 to $100.00. The current price Cullen/Frost Bankers (CFR) is trading at is $89.67, which is out of the analyst's predicted range.